MARKET

OCS

OCS

Oculis Holding
NASDAQ
9.27
-0.14
-1.49%
After Hours: 9.25 -0.02 -0.22% 19:30 09/25 EDT
OPEN
9.71
PREV CLOSE
9.41
HIGH
9.71
LOW
9.10
VOLUME
239.61K
TURNOVER
--
52 WEEK HIGH
34.48
52 WEEK LOW
9.10
MARKET CAP
572.26M
P/E (TTM)
-5.3720
1D
5D
1M
3M
1Y
5Y
1D
Strength Seen in Halozyme Therapeutics (HALO): Can Its 3.3% Jump Turn into More Strength?
NASDAQ · 4d ago
Weekly Report: what happened at OCS last week (0914-0918)?
Weekly Report · 6d ago
Apple To Rally Around 13%? Here Are 10 Top Analyst Forecasts For Friday
Benzinga · 09/18 12:31
Oculis Holding Price Target Raised to $39.00/Share From $26.00 by HC Wainwright & Co.
Dow Jones · 09/18 11:02
Oculis Holding Is Maintained at Buy by HC Wainwright & Co.
Dow Jones · 09/18 11:02
HC Wainwright & Co. Maintains Buy on Oculis Holding, Raises Price Target to $39
Benzinga · 09/18 10:53
Analysts Have Conflicting Sentiments on These Healthcare Companies: Aethlon Medical (AEMD), Xenon (XENE) and Oculis Holding (OCS)
TipRanks · 09/18 10:20
Oculis price target raised to $39 from $26 at H.C. Wainwright
TipRanks · 09/18 10:15
More
About OCS
Oculis Holding AG is a Switzerland-based company primally engaged in biotechnology sector. The Company is focused on the development of eye disease treatment for ophthalmology. It includes OCS-01, based on the OPTIREACH technology, a topical retinal candidate for diabetic macular edema (DME); OCS-02, a topical biologic candidate for dry eye disease (DED) in a form of a single chain antibody fragment; and OCS-05, a disease modifying candidate for acute optic neuritis (AON) and for other neuro-ophtha disorders such as glaucoma, diabetic retinopathy, geographic atrophy, and neurotrophic keratitis. The Company have operations in the USA, Europe and China. Ocullis deliver treatments to patients worldwide.

Webull offers Oculis Holding AG stock information, including NASDAQ: OCS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OCS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OCS stock methods without spending real money on the virtual paper trading platform.